Jacobs Levy Equity Management’s Applied Genetic Technologies Corporation AGTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-348,560
| Closed | -$1.05M | – | 1120 |
|
|
2021
Q3 | $1.05M | Sell |
348,560
-108,265
| -24% | -$326K | 0.01% | 741 |
|
|
2021
Q2 | $1.79M | Sell |
456,825
-12,799
| -3% | -$50K | 0.01% | 624 |
|
|
2021
Q1 | $2.38M | Buy |
469,624
+379,716
| +422% | +$1.93M | 0.02% | 564 |
|
|
2020
Q4 | $368K | Buy |
89,908
+18,047
| +25% | +$73.9K | ﹤0.01% | 891 |
|
|
2020
Q3 | $349K | Sell |
71,861
-38,452
| -35% | -$187K | ﹤0.01% | 869 |
|
|
2020
Q2 | $611K | Sell |
110,313
-41,698
| -27% | -$231K | 0.01% | 756 |
|
|
2020
Q1 | $499K | Buy |
152,011
+48,445
| +47% | +$159K | 0.01% | 754 |
|
|
2019
Q4 | $468K | Buy |
103,566
+20,942
| +25% | +$94.6K | ﹤0.01% | 790 |
|
|
2019
Q3 | $344K | Buy |
82,624
+1,000
| +1% | +$4.16K | ﹤0.01% | 767 |
|
|
2019
Q2 | $309K | Buy |
81,624
+18,265
| +29% | +$69.1K | ﹤0.01% | 808 |
|
|
2019
Q1 | $265K | Hold |
63,359
| – | – | ﹤0.01% | 855 |
|
|
2018
Q4 | $158K | Sell |
63,359
-14,000
| -18% | -$34.9K | ﹤0.01% | 912 |
|
|
2018
Q3 | $565K | Buy |
77,359
+7,500
| +11% | +$54.8K | 0.01% | 752 |
|
|
2018
Q2 | $258K | Buy |
+69,859
| New | +$258K | ﹤0.01% | 916 |
|
|
2018
Q1 | – | Sell |
-14,000
| Closed | -$50K | – | 1090 |
|
|
2017
Q4 | $50K | Buy |
+14,000
| New | +$50K | ﹤0.01% | 967 |
|
|
2017
Q3 | – | Sell |
-20,900
| Closed | -$107K | – | 1033 |
|
|
2017
Q2 | $107K | Sell |
20,900
-5,900
| -22% | -$30.2K | ﹤0.01% | 892 |
|
|
2017
Q1 | $185K | Buy |
26,800
+400
| +2% | +$2.76K | ﹤0.01% | 808 |
|
|
2016
Q4 | $247K | Buy |
+26,400
| New | +$247K | ﹤0.01% | 801 |
|